Delivery Order SPE2DE21D7020-SPE2D624F2WU4

Award Date 7/9/24
Potential Completion Date 7/16/24
Potential Value $18K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The $21,316.72 fixed-price contract is for the Eluvia Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of December 12, 2024. Boston Scientific is the prime contractor and sole provider for this award, which is not associated with a set-aside program. The contract builds on Boston...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, doing business as Boston Scientific, for the supply of Eluvia Drug Eluting Stents. The contract has a ceiling value of $19,894.22 and an ultimate completion date of September 27, 2024. It is not set aside for any specific socioeconomic program. Boston Scientific is a leading manufacturer of medical devices that provides innovative, minimally invasive solutions to federal healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation for the procurement of the Eluvia Drug Eluting Stent, a medical device. The contract has a total ceiling value of $8,464.00 and is set to expire on September 19, 2024. The contract is a fixed-price with economic price adjustment arrangement. This order is part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle that Boston Scientific holds with the Department of...
This is a $12,794.40 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract is for the delivery of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of August 28, 2024 and does not have a set-aside designation. Boston Scientific is an experienced federal contractor, having received numerous contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices, for the delivery of the ELUVIA Drug Eluting Stent. The $5,122.84 fixed-price with economic price adjustment contract has a completion date of December 20, 2024. Boston Scientific, doing business as Boston Scientific, specializes in developing innovative, minimally invasive medical technologies for use in various clinical areas, including...
This is a federal delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Boston Scientific Corp, doing business as Boston Scientific. The $19,658.62 fixed-price contract with economic price adjustment is for the delivery of the ELUVIA Drug Eluting Stent, a specialized medical device. The contract has a period of performance ending on July 18, 2024. This order was issued under a larger indefinite delivery/indefinite quantity (IDIQ) contract...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Boston Scientific Corporation for the supply of ELUVIA Drug Eluting Stents. The fixed-price contract has a ceiling value of $4,787.60 and an ultimate completion date of August 20, 2024. It was awarded on August 13, 2024 and does not have a set-aside designation. Boston Scientific Corporation is a leading medical device manufacturer that provides a wide range of innovative,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company based in Marlborough, Massachusetts. The contract, valued at $42,312.11, is for the procurement of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract is a fixed-price with economic price adjustment and has an ultimate completion date of March 20, 2025. This award is not associated with a set-aside program. Boston...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading medical device manufacturer, for the supply of the ELUVIA Drug Eluting Stent. The contract has a ceiling value of $8,464.00 and an ultimate completion date of September 12, 2024. The contract is a fixed-price with economic price adjustment and is not set aside. Boston Scientific, doing business as Boston Scientific, is the prime contractor and the manufacturer of...
This is a $4,232 fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Boston Scientific Corp. The contract is for the Eluvia Drug Eluting Stent, a medical device product. Boston Scientific is a leading manufacturer of cardiovascular and neurostimulation devices that holds multiple contracts and IDIQs with federal agencies like the VA and DHA. The award is not associated with a set-aside program. While Boston Scientific has received larger IDIQ...
  • SPE2DE21D7020
    Indefinite Delivery Contract
  • SPE2DE21D7020-SPE2D624F2WU4
    Delivery Order

This is a delivery order award under contract SPE2DE21D7020 to Boston Scientific Corp, doing business as Boston Scientific, a leading manufacturer of medical devices. The $17,871.88 fixed-price with economic price adjustment contract is to provide the Eluvia Drug Eluting Stent to the Defense Logistics Agency (DLA), a defense agency. The award has a ceiling value of $17,871.88 and an ultimate completion date of July 16, 2024. Boston Scientific is not a small business contractor, as this contract did not utilize a set-aside. The company has received other federal contract awards, including a $295 million indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Veterans Affairs (VA) for surgical implants and related services, as well as a $3.5 million IDIQ for the TheraSphere Y-90 radioactive microspheres used in interventional radiology treatments.

Generated 10/8/24, 9:16 AM